Stephanie Baillif Selected Research

Proton Therapy

11/2022	Phantom vision after eye removal: prevalence, features and related risk factors.
9/2022	OCT-angiography for the diagnosis of radiation maculopathy in patients treated with proton beam therapy: A 2-year prospective study.
3/2020	Ultra-widefield fundus photography for radiation therapy planning of ocular tumours.
12/2019	Oncologic and visual outcomes after postoperative proton therapy of localized conjunctival melanomas.
10/2018	[Management of uveal melanomas, guidelines for oncologists].
1/2018	Proton Beam Therapy for Iris Melanomas in 107 Patients.
1/2017	Dry Eye Syndrome After Proton Therapy of Ocular Melanomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephanie Baillif Research Topics

Disease

5	Melanoma (Melanoma, Malignant) 09/2022 - 01/2017
3	Glaucoma 04/2024 - 08/2021
3	Neoplasms (Cancer) 12/2019 - 01/2017
2	Uveal melanoma 11/2022 - 08/2021
2	Eye Pain 11/2022 - 08/2021
2	Retinal Detachment (Retinal Detachments) 08/2021 - 01/2021
2	Macular Edema 01/2021 - 01/2021
1	Carcinoma (Carcinomatosis) 04/2024
1	Fistula 04/2024
1	Necrosis 04/2024
1	Retinal Artery Occlusion 09/2023
1	Macular Degeneration (Age-Related Maculopathy) 09/2022
1	Cataract (Cataracts) 09/2022
1	Uveitis 09/2021
1	Latent Tuberculosis 09/2021
1	Phantom Limb (Phantom Limbs) 08/2021
1	Endophthalmitis (Ophthalmia) 08/2021
1	Wounds and Injuries (Trauma) 08/2021
1	Hemorrhage 01/2021
1	Epiretinal Membrane (Epiretinal Membranes) 01/2021
1	Polyps 01/2020
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2017

Drug/Important Bio-Agent (IBA)

1	Fluorescein (Funduscein)FDA LinkGeneric 09/2023
1	Retinaldehyde (Retinal)IBA 09/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 08/2021
1	Fluocinolone Acetonide (Capex)FDA LinkGeneric 01/2021
1	afliberceptIBA 01/2021
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2020
1	P 707IBA 01/2017

Therapy/Procedure

7	Proton Therapy 11/2022 - 01/2017
2	Radiotherapy 04/2024 - 10/2018
2	Vitrectomy 09/2022 - 01/2021
2	Therapeutics 09/2021 - 10/2018
2	Brachytherapy 03/2020 - 10/2018
1	Intraocular Lenses (Intraocular Lens) 04/2024
1	Hyperbaric Oxygenation 09/2023
1	Injections 09/2022
1	Lasers (Laser) 06/2022
1	Trabeculectomy (Trabeculoplasty) 06/2022
1	Surgical Amputation (Amputations) 08/2021
1	Traction 01/2021
1	Intravitreal Injections 01/2021
1	Cryotherapy (Therapy, Cold) 12/2019
1	Immunotherapy 10/2018
1	Conservative Treatment 10/2018
1	Drug Therapy (Chemotherapy) 10/2018